IRIS
Grimaldi, Luigi Maria Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 33
EU - Europa 12
Totale 45
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 28
IT - Italia 12
HK - Hong Kong 5
Totale 45
Salva come PNG Salva come JPEG
Città #
Rome 10
Hong Kong 5
Singapore 3
Milan 1
Totale 19
Salva come PNG Salva come JPEG
Nome #
The immunopathology of epilepsy 7
The pervasiveness of interleukin-1 in Alzheimer pathogenesis: A role for specific polymorphisms in disease risk 4
Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study 4
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective 3
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 3
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 3
Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register 3
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 3
Randomized trial of daily high-dose Vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a 3
Signs and symptoms of COVID-19 in patients with multiple sclerosis 3
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study 3
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 3
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial 3
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 2
Incidence of multiple sclerosis in the province of Catania. A geo-epidemiological study 2
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study) 2
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 2
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 2
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 2
A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis 2
The molecular anatomy of human Hps60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential patogenetic role of anti-chaperonin immunity in myasthenia gravis 2
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 2
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience 2
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study 2
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 2
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study 2
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 2
Natalizumab therapy of multiple sclerosis: Recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society 1
The interleukin 1-β exonic (+3953) polymorphism does not alter in vitro protein secretion 1
The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome in patients 1
Neuroinflammation and the genetics of Alzheimer's disease: The search for a pro-inflammatory phenotype 1
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients 1
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study 1
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study 1
γ-interferon activates a new Ca2+ influx in T-lymphocytes from multiple sclerosis patients 1
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymerc mixture, in patients with relapsing-remitting multiple sclerosis 1
γ Interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis 1
Three years of experience: the Italian registry and safety data update 1
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy 1
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial 1
The role of IL-1 gene cluster in longevity: A study in Italian population 1
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 1
Totale 88
Salva come PNG Salva come JPEG
Categoria #
all - tutte 264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202588 0 0 0 0 0 0 62 26 0 0 0 0
Totale 88